(Q40479195)

20 September 2017

Epigenetic status and aberrant expression of the maspin gene in human hepato-biliary tract carcinomas. (English)

1 reference

20 September 2017

2

Chihaya Maesawa

1 reference

20 September 2017

5

Satoshi Ogasawara

1 reference

20 September 2017

Kentaro Fujisawa

1

1 reference

20 September 2017

Ryo Sato

3

1 reference

20 September 2017

Kei Wada

4

1 reference

20 September 2017

Yuji Akiyama

6

1 reference

20 September 2017

Masaru Takeda

7

1 reference

20 September 2017

Tomohiro Fujita

8

1 reference

20 September 2017

Koki Otsuka

9

1 reference

20 September 2017

Taro Higuchi

10

1 reference

20 September 2017

Kazuyuki Suzuki

11

1 reference

20 September 2017

Kazuyoshi Saito

12

1 reference

20 September 2017

Tomoyuki Masuda

13

1 reference

20 September 2017

language of work or name

1 reference

1 February 2005

1 reference

20 September 2017

Laboratory Investigation

1 reference

20 September 2017

85

1 reference

20 September 2017

2

1 reference

20 September 2017

214-224

1 reference

https://scigraph.springernature.com/pub.10.1038/labinvest.3700214

20 September 2017

0 references

cites work

Maspin, a serpin with tumor-suppressing activity in human mammary epithelial cells

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700214

Maspin Regulates Different Signaling Pathways for Motility and Adhesion in Aggressive Breast Cancer Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700214

The tumor suppressor maspin does not undergo the stressed to relaxed transition or inhibit trypsin-like serine proteases. Evidence that maspin is not a protease inhibitory serpin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700214

Expression of maspin predicts poor prognosis in breast-cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700214

Down regulation of the tumor suppressor gene maspin in breast carcinoma is associated with a higher risk of distant metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700214

Decline in the expression of the serine proteinase inhibitor maspin is associated with tumour progression in ductal carcinomas of the breast

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700214

Expression of the p53 and Maspin protein in primary prostate cancer: correlation with clinical features

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700214

High tumoral maspin expression is associated with improved survival of patients with oral squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700214

Cell-Type-Specific Repression of the Maspin Gene Is Disrupted Frequently by Demethylation at the Promoter Region in Gastric Intestinal Metaplasia and Cancer Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700214

Disruption of cell-type-specific methylation at the Maspin gene promoter is frequently involved in undifferentiated thyroid cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700214

Aberrant expression of the maspin gene associated with epigenetic modification in melanoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700214

X inactivation, differentiation, and DNA methylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700214

Role for DNA methylation in the control of cell type specific maspin expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700214

High sensitivity mapping of methylated cytosines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700214

Hypermethylation and histone deacetylation lead to silencing of the maspin gene in human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700214

Human pancreatic carcinoma cells activate maspin expression through loss of epigenetic control

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700214

Clinicopathological significance and molecular regulation of maspin expression in ductal adenocarcinoma of the pancreas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700214

Mutant p53 and aberrant cytosine methylation cooperate to silence gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700214

p53 alteration is not an independent prognostic indicator, but affects the efficacy of adjuvant chemotherapy in human pancreatic cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700214

Differential histone H3 Lys-9 and Lys-27 methylation profiles on the X chromosome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700214

Silencing of imprinted CDKN1C gene expression is associated with loss of CpG and histone H3 lysine 9 methylation at DMR-LIT1 in esophageal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700214

Chemistry. How are alkynes scrambled?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700214

7 January 2021

Epigenetic silencing of maspin gene expression in human breast cancers

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700214

7 January 2021

p53 regulates the expression of the tumor suppressor gene maspin

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700214

7 January 2021

Expression of maspin in colon cancers: its relationship with p53 expression and microvessel density

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700214

7 January 2021

10.1038/LABINVEST.3700214

Identifiers

DOI

1 reference

20 September 2017

1 reference